Infectious Disease Control News & Press Release Distribution

Infectious Disease Control

APAC
Global

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. NYON, Switzerland, July 8, 2021 /PRNewswire/ -- Today sees the launch of Let's treat it right, a major new health education campaign d...

2021-07-08 16:00 2084

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

King Power Group Launches King Power Phuket Sandbox : Shop Eat Play Stay Safe In supporting TAT's PHUKET SANDBOX Campaign

PHUKET, Thailand, July 8, 2021 /PRNewswire/ -- King Power Group has launched King Power Phuket Sandbox Shop Eat Play Stay Safe to welcome back fully vaccinated international tourists without quarantine requirements to the resort island in support of Tourism Authority ofThailand's PHUKET SANDBOX c...

2021-07-08 15:26 2344

Just 5 minutes: Game-changing PCR to complete nucleic acid amplification, Si-Gene Biotech help out against COVID 19

SHANGHAI, July 8, 2021 /PRNewswire/ -- As is known, nucleic acid detection is currently the "golden standard" of coronavirus detection and has the high sensitivity and specificity characteristics in early diagnosis. The most common method for detecting novel coronavirus-specific nucleic acid sequ...

2021-07-08 11:28 2586

Triple Stimulus Voucher Mobile Payments Yield Astonishing Results--Kaohsiung New Yan Cheng Circle Revenues Double in 2nd Half of 2020

TAIPEI, July 7, 2021 /PRNewswire/ -- To respond to Taiwan's epidemic prevention measures and ease the challenges facing the shopping district due to the spread of COVID-19, Kaohsiung's New Yan Cheng Circle Prosperity Union introduced Triple Stimulus Voucher mobile payments in stores inJuly 2020, ...

2021-07-07 09:00 2200

Triple Stimulus Voucher Mobile Payments Yield Astonishing Results--Kaohsiung New Yan Cheng Circle Revenues Double in 2nd Half of 2020

Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax

PROVIDENCE, R.I., July 7, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr.Amy Rosenberg is leaving the FDA's Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and Protein Therapeutics. Dr. Rosenber...

2021-07-07 01:43 3088

Tianjin Haihe Media Group presents an extraordinary story of a TCM doctor and his battle against COVID-19 in China

TIANJIN, China, July 3, 2021 /PRNewswire/ -- Zhang Boli, director of the Tianjin University of Traditional Chinese Medicine inChina, was awarded with the national honorary title "the People's Hero" by the Chinese central government for his outstanding contribution to the country's fight against t...

2021-07-05 09:14 5024

Tianjin Haihe Media Group presents an extraordinary story of a TCM doctor and his battle against COVID-19 in China

Pandemic fight, economy among China topics of interest in survey

BEIJING, July 2, 2021 /PRNewswire/ -- A report from chinadaily.com.cn: An online survey which began in February by China Daily and its global media outlets found thatChina's anti-pandemic experience and economic development were the top topics global netizens are most interested in.

2021-07-02 21:50 3359

Pandemic fight, economy among China topics of interest in survey

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

TIANJIN, China, July 2, 2021 /PRNewswire/ -- In September 2020, Zhang Boli was awarded with the national honorary title "the People's Hero" by the Chinese central government for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to c...

2021-07-02 21:07 4393

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology

SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.

2021-07-01 21:00 2630

Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology

InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization

BOULDER, Colo., July 1, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Polio D-antigen quantification kit for r...

2021-07-01 15:00 1879

Built on VeChainThor, VeTrust Is Now Adopted By Local Chinese Government, Helping 300k+ Citizens Return To Normalcy

SHANGHAI, June 30, 2021 /PRNewswire/ -- On the 9th of September 2020 during the on-going impact of the COVID-19 pandemic,VeChain, in conjunction with DNV, introduced the blockchain-based risk self-assessment application, VeTrust. Built on the VeChainThor public blockchain, it combines DNV's infec...

2021-06-30 20:00 4374

Built on VeChainThor, VeTrust Is Now Adopted By Local Chinese Government, Helping 300k+ Citizens Return To Normalcy

Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility

* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million doses in 2021 and Gavi has options for an additional 350 million doses in 2022 * Clover will receive a significant upfront payment, a payment upon positive Phase 2/3 data, potential payments upon...

2021-06-30 16:00 3271

GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)

* GSK Singapore has signed an Advance Purchase Agreement with the Government ofSingapore for sotrovimab * Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization * Announcement follow...

2021-06-30 06:30 3198

GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)

1 ... 30 31 32 3334